Simply, it is defined by evaluating the tumor immune microenvironment through various immune markers such as CD3, CD8, CD68, PD1, and PD-L1 in tissue sections in lung and colorectal cancer10–12, and potentially offers a relatively uniform parameter of prognostic and predictive values. Here, CD68 is linked to neoplasm.